Not Signed In -
Hydroxychloroquine |
Plaquenil |
Article: Hydroxychloroquine
 | |
| Hydroxychloroquine | |
| Systematic (IUPAC) name | |
| 2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol | |
| Identifiers | |
| CAS number | 118-42-3 |
| ATC code | P01BA02 |
| PubChem | 3652 |
| Chemical data | |
| Formula | C18H26N3ClO |
| Mol. weight | 335.872 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 1-2 months |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. | D (Au), C (U.S.) |
| Legal status | POM (UK), ℞-only (U.S.) |
| Routes | Oral |
Hydroxychloroquine is an antimalarial drug, sold under the trade name Plaquenil®, also used to reduce inflammation and in the treatment of arthritis (see Disease-modifying antirheumatic drugs) and lupus.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Category: Pharmacology stubs
Resources
- Hydroxychloroquine (Drug Digest)
- Plaquenil (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
